Seemant Chaturvedi/LinkedIn
Sep 6, 2025, 13:18
Seemant Chaturvedi: Will Tirofiban Benefit Patients with Acute Ischemic Stroke?
NEJM Journal Watch shared on X:
”Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi
Stay informed on all science in the field of thrombosis with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy